Poging GOUD - Vrij

'TCS not dependent on H-1B visas'

Business Standard

|

October 13, 2025

India’s largest information technology (IT) services provider Tata Consultancy Services (TCS) has been in the news for the past three months, first for laying off around 12,000 employees and more recently over the H-1B visa issue. In an interview with Shivani Shinde in Mumbai, Chief Executive Officer K Krithivasan discusses the layoffs, visa challenges, AI strategy, and the company’s next major focus on data centres. Edited excerpts:

'TCS not dependent on H-1B visas'

You mentioned that TCS performed well in the second quarter despite macro challenges, yet uncertainty persists. How do you see the next two quarters shaping up?

■ There is a small positive bias, as the number of deferrals — where projects are being paused — has come down slightly sequentially. Almost all verticals, except the consumer business, have turned positive. Across geographies, all except the UK have performed well. In the UK, we faced a specific situation in an insurance claim where the price per policy saw a steep decline. What's also making us confident is our big-bet strategy.

Almost all service lines are driving growth, particularly AI and data, albeit from a small base.

The recent US decisions on H-1B visas have significantly impacted the industry. What's your perspective on this environment, and what implications does it have for the largest IT services player?

■ We have 31,000 to 32,000 employees in the US, of whom only 11,000 to 12,000 are on H-1B visas, while the rest are on other types of visas. We have been progressively increasing local workforce participation, which will continue because the way of work has changed with new kinds of projects and AI coming into play, where you need to work closely with the customer and need different skill sets. It is not just about engineering skills anymore; there is a growing demand for creative thinking and prompt engineering skills. In FY26, we sent just 500 people from India to the US on H-1B visas, which means we can survive without them (H-1B visas). There is no dependence on H-1B visas.

But, for a long period, H1-B visas were part of not only the cost policy but also the retention policy...

MEER VERHALEN VAN Business Standard

Business Standard

Labour Codes impact: HCL tech profit slips 11%

Q3 top line beats Street estimates, bottom line misses expectations

time to read

2 mins

January 13, 2026

Business Standard

New labour Codes, restructuring weigh on TCS earnings

Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Black drives the thrill for car buyers

Sees a surge in yearly sales, while white remains practical 'utility king'

time to read

2 mins

January 13, 2026

Business Standard

CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS

Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be

time to read

2 mins

January 13, 2026

Business Standard

Business Standard

China’s PVC rethink to help India pipe makers

Supply likely to tighten after S-PVC rebate withdrawal

time to read

2 mins

January 13, 2026

Business Standard

Responsible growth

India must ensure data centres are sustainable

time to read

2 mins

January 13, 2026

Business Standard

India’s GenZ is full of creativity: PM

Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Iran wants to negotiate after threats to attack, says Trump

At least 572 killed in protests; Tehran says situation ‘under full control’

time to read

2 mins

January 13, 2026

Business Standard

Insurers knock on Irdai door for clarity on director overlap ban

CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY

time to read

2 mins

January 13, 2026

Business Standard

Delhi HC allows Zydus to sell generic version of cancer drug

Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.

time to read

1 min

January 13, 2026

Listen

Translate

Share

-
+

Change font size